Table 2.
Neurologic manifestations of HIV/AIDS in relation to outcome in 347 patients
| Diagnosis | n(%) | Dead(156) n(%) | Poor outcome(21) n(%) | Improved(170) n(%) |
|---|---|---|---|---|
| cerebral toxoplasmosis | 127(36.6) | 56(44.1) | 9(7.1) | 62(48.8) |
| Tuberculosis meningitis | 78(22.5) | 42(53.8) | 2(2.6) | 34(43.6) |
| Cryptococcal meningitis | 77(22.2) | 37(48.1) | 3(3.8) | 37(48.1) |
| Bacterial meningitis | 24(6.9) | 8(33.3) | 2(8.3) | 14(58.3) |
| Tuberculoma | 10(2.9) | 4(40) | 1(10) | 5(50) |
| Neurosyphilis | 9(2.6) | 0 | 1(11.1) | 8(88.9) |
| Stroke | 8(2.3) | 3(37.5) | 0 | 5(62.5) |
| GBS | 5(1.4) | 1(20) | 0 | 4(80) |
| Tuberculos spondylitis | 5(1.4) | 1(20) | 2(40) | 2(40) |
| Primary CNS lymphoma | 3(0.9) | 3(100) | 0 | 0 |
| CIDP | 3(0.9) | 0 | 0 | 3(100) |
| PML | 2(0.6) | 1(50) | 0 | 1(50) |
| Others | 3(0.9) | 0 | 2(66.7) | 1(33.3) |
Note: GBS Guillain-Barre syndrome, CNS central nervous system, CIDP chronic inflammatory demyelinating polyneuropathy, PML progressive multifocal leukoencephalopathy, Others = pseudotumor cerebri (n = 1), neurocycticercosis (n = 1), HIV-encephalopathy (n = 1). Stroke: ischemic (n = 6), Hemorrhagic (n = 2).